ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the proposed sale of 89bio, Inc. to Roche for its shareholders [1] Transaction Details - Under the terms of the proposed transaction, 89bio shareholders will receive $14.50 per share in cash at closing [1] - Additionally, shareholders will receive a non-tradeable contingent value right to receive certain contingent payments of up to an aggregate of $6.00 per share upon achievement of specified milestones [1]